New technology could cut tissue analysis time from weeks to days, advancing research workflows and improving future patient care pathways Vancouver, BC — A new partnership between Providence Health Care… Read More
Download PDF Research suggests AI may help identify more aggressive breast cancers and perform comparably to experts in breast cancer screening MARLBOROUGH, Mass — Data from two groundbreaking studies evaluating… Read More
VANCOUVER, BC — ME Therapeutics Holdings Inc. (“ME Therapeutics”) a publicly listed biotechnology company working on novel cancer fighting drugs in the field of immuno-oncology, is pleased to announce its… Read More
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson’s disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the… Read More
– Food and Drug Administration granted Breakthrough Therapy Designation for povetacicept in IgA nephropathy; on track to file for accelerated approval in the U.S. in H1 2026 if 36-week interim analysis… Read More
